The New Criterion

Viralytics (VLA) $1.69 Viralytics chief Malcolm McColl recently told a biotech forum that after a quiet 2017 for global takeover activity in the pharmaceutical sector, Trump’s tax cuts would fire up activity this year. That’s because corporates will have more…